1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing arthropod-borne viral infections with focus on developing new diagnostics
5.2.2. Increasing geographic spread and diseases incidence of arboviral infections
5.2.3. Government initiatives for developing diagnostics for Arthropod-borne viral detection
5.3. Restraints
5.3.1. Lack of physician awareness of diagnostic tests
5.4. Opportunities
5.4.1. Rising acceptance of ELISA-based test diagnostics in developing countries
5.4.2. Technological advancements in testing methods
5.5. Challenges
5.5.1. Difficulties in developing arbovirus animal models for research study and vaccine development

6. Arthropod-borne Viral Infections Testing Market, by Test Type
6.1. Introduction
6.2. Cultural Tests
6.3. Immunoassays
6.4. Molecular Tests

7. Arthropod-borne Viral Infections Testing Market, by End-user
7.1. Introduction
7.2. Diagnostic Centers
7.3. Hospitals
7.4. Research Centers

8. Americas Arthropod-borne Viral Infections Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Arthropod-borne Viral Infections Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Arthropod-borne Viral Infections Testing Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. ARUP Laboratories
12.3. B.l.international Private Limited
12.4. bioMerieux SA
12.5. bioMérieux S.A.
12.6. Chembio Diagnostics, Inc.
12.7. Clongen Laboratories, LLC
12.8. Coppe Laboratories
12.9. EUROIMMUN AG
12.10. Merck KGaA
12.11. Quest Diagnostics Incorporated
12.12. Sonora Quest Laboratories LLC
12.13. Thermo Fisher Scientific Inc.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (%)
FIGURE 5. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY TEST TYPE, 2026
FIGURE 7. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY CULTURAL TESTS, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY CULTURAL TESTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2026 (USD MILLION)
FIGURE 10. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 11. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY MOLECULAR TESTS, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 14. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY END-USER, 2026
FIGURE 16. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY RESEARCH CENTERS, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. AMERICAS ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 23. ARGENTINA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 24. BRAZIL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 25. CANADA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 26. MEXICO ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 27. UNITED STATES ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 28. ASIA-PACIFIC ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 29. AUSTRALIA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 30. CHINA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 31. INDIA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. INDONESIA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. JAPAN ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. MALAYSIA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. PHILIPPINES ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. SINGAPORE ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. SOUTH KOREA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. TAIWAN ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. THAILAND ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. FRANCE ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. GERMANY ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. ITALY ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. NETHERLANDS ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. QATAR ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. RUSSIA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. SAUDI ARABIA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. SOUTH AFRICA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. SPAIN ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. UNITED ARAB EMIRATES ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. UNITED KINGDOM ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 53. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 54. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY CULTURAL TESTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. AMERICAS ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 13. ARGENTINA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 14. BRAZIL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 15. CANADA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. MEXICO ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. ASIA-PACIFIC ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. AUSTRALIA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. CHINA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. INDIA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. INDONESIA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. JAPAN ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. MALAYSIA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. PHILIPPINES ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. SINGAPORE ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. SOUTH KOREA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. TAIWAN ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. THAILAND ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. FRANCE ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. GERMANY ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. ITALY ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. NETHERLANDS ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. QATAR ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. RUSSIA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. SAUDI ARABIA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. SOUTH AFRICA ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. SPAIN ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. UNITED ARAB EMIRATES ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. UNITED KINGDOM ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: SCORES
TABLE 43. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: BUSINESS STRATEGY
TABLE 44. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: PRODUCT SATISFACTION
TABLE 45. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: RANKING
TABLE 46. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 47. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: MERGER & ACQUISITION
TABLE 48. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 49. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 50. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: INVESTMENT & FUNDING
TABLE 51. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 52. GLOBAL ARTHROPOD-BORNE VIRAL INFECTIONS TESTING MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
ARUP Laboratories
B.l.international Private Limited
bioMerieux SA
bioMérieux S.A.
Chembio Diagnostics, Inc.
Clongen Laboratories, LLC
Coppe Laboratories
EUROIMMUN AG
Merck KGaA
Quest Diagnostics Incorporated
Sonora Quest Laboratories LLC
Thermo Fisher Scientific Inc.